A new device call the Animalarm, which sends dog owners an SMS text message if the temperature in their car exceeds a preset threshold, has been launched this week.
Apparently, you can also ring the device to check what the temperature is inside your car.
The Animalarm sells for £108 inc. VAT from www.animalarm.co.uk.
Now all we need is a bit of sun.
1004 veterinary professionals attended VET Festival to hear talks from a line up of 21 speakers from around the world. On the Friday night, VETFest Live provided an opportunity for delegates to network and relax in front of a number of acts, including Hunter and the Bear, Lucy Spraggan and Morrissey & Marshall.
Noel said: "I think that change is inevitable within veterinary education. My experience with the students of today is that they wish to embrace new learning formats and are especially enthusiastic about learning environments where didactic lectures become an immersive experience. My goal therefore was to achieve the perfect mix of education and a chilled-out festival atmosphere.
"We are learning all the time, and we invite suggestions. I take very seriously the commitment I voiced in the welcome address, which is to reinvest every penny for the greater good for animals and the profession. I sincerely believe that vets and vet nurses will over time question where their money is spent and will take a good hard look not only at what value they get for their investment, but also where their money actually goes."
Picture: Richard Dunwoody.
The Brexit Barometer report draws on insights from 16 animal medicines companies and other stakeholders. 95% of those who contributed to the report, drawn up after NOAH’s Brexit event in May, said that they are optimistic about the future of animal health and welfare in the UK.
On the broader future of the industry, contributors to the report were more uncertain: 40% 'in the middle', 30% 'optimistic' and 25% 'pessimistic'. In contrast to animal welfare, contributors were most pessimistic about the future of trade and exports in relation to animal health.
While optimism about animal welfare remains high, NOAH says the animal medicines industry needs a continuation of its high standards of health and welfare to help tackle antibiotic resistance and to put the UK in a strong influencing position with our ability to trade. Six key measures in relation to health and welfare that Government needs to take to realise the opportunities were outlined in the report. They are:
• Maintaining the current Animal Welfare Acts and evolving them to secure the UK’s position from ‘Day 0’• Ensuring the industry is not disadvantaged by lack of veterinary medicines availability during the transition period and beyond, as new products come on the market• Ensuring that veterinary services are available in inner city and rural areas throughout the UK• Ensuring that a cross-border programme is in place to maintain cooperation between the UK and Europe• Recognising that animal diseases do not respect borders and to co-operate with our European neighbours to ensure that appropriate measures are in place to prevent and control disease outbreaks• Balancing first-class welfare standards with creating a level playing field for UK farmers and ensuring that British product does not become uncompetitive.
NOAH Chief Executive, Dawn Howard said: "While the Barometer showed that a large proportion of the industry was undecided when it comes to overall future of our sector, it tells us loudly and clearly that the sector sees a very clear opportunity for the UK to show leadership when it comes to animal health and welfare. What is vital now is that Government collaborates closely with industry and heeds its advice to realise this opportunity and leverage these high levels of optimism. We must not forget that veterinary medicines support the health and welfare of the UK’s livestock and pets and we stand ready to work with industry and Government to help make this happen."
BVA President Gudrun Ravetz said: "We have a unique selling point as 'UK PLC' around our high standards of animal welfare and food safety and these must be maintained in the wake of Brexit. This means tackling issues including veterinary involvement from farm to fork to underpin animal health, welfare and public health, through to guaranteeing working rights for vets and veterinary nurses. It is therefore vital that animal welfare is included in all trade negotiations."
The report can be read in full here: https://www.noah.co.uk/wp-content/uploads/2017/07/NOAH-Brexit-Barometer-Summer-17-6pp-A4-vf.pdf
The free app is designed to help to track changes and improvements in a dog’s health during treatment.
The app uses questionnaires to monitor clinical signs and quality of life and includes reminders for when checkups with routine blood tests should be carried out, which Dechra says are recommended at 10 days, 4 weeks, 12 weeks and every 3 months thereafter.
The app also sends pet owners daily reminders to administer medication to their dog.
Sarah Musgrave, companion animal brand manager at Dechra, said: “Continuous and consistent monitoring is key to finding the right Vetoryl dose for a dog with Cushing’s and restoring its health.
"The new Cushing’s syndrome treatment and monitoring app is a useful tool to help owners quickly and easily record and track any medical and lifestyle changes in dogs being treated with Vetoryl, which can then be shared with their vet during check-ups.”
To download the app, search for 'Cushing's monitoring' on either Apple's App Store or the Google Play Store.
The Royal Veterinary College is calling for dogs diagnosed with osteoarthritis to take part in a revolutionary study in which their movement will be monitored by a state-of-the-art recorder.
The recorder (pictured right), which is attached to the dog's collar, uses miniaturised sensors based on those found in smart phones. It can distinguish between different activities independent of the dog's location, allowing constant recording of movement in the dog's home environment, to complement the traditional clinical assessments carried out as part of the trial.
The study is being carried out to assess the efficacy of the joint mobility supplement Yumove in reducing the clinical signs of osteoarthritis. This will be the first time that the real effect of a joint supplement has been measured.
Dr. John Howie, co-founder of Lintbells, the company that makes Yumove, said: "This is the first time the real effect of a joint supplement has been measured and it will be a very fast trial. Yumove is a supplement that has been specifically formulated to include glucosamine, chondroitin and Omega 3 from green-lipped mussel, which all work together to increase joint mobility and provide an anti-inflammatory effect."
The research is being led by Dr Matthew Pead the RVC's Academic Director of Professional Assessment and Development. He said: "The results of this study will have important clinical implications for the understanding and treatment of canine OA, with the ultimate aim of advancing the treatment of this difficult and degenerative disease for the benefit of many thousands of dogs."
Any veterinary surgeon with a patient in their practice that might benefit from this study is invited to refer them. Further details are available the Clinical Investigation Centre at the Royal Veterinary College - email cic@rvc.ac.uk or phone 01707 666605.
The new.graduatevet programme (or 'Dot' programme) offers hands-on surgical training and seminars from Advanced Practitioners at Pets'n'Vets' Roundhouse Veterinary Hospital in Glasgow, together with a dedicated website for all new and recent graduates: www.new.graduatevet.co.uk.
Pets'n'Vets says the programme has now been further enhanced by the addition of new CPD elements and the provision of additional monthly benchmarking and seminars.
Oliver Jackson, a partner at Pets‘n’Vets, said: "This is the best well-rounded, supported and unique new graduate training programme available in Scotland. Support is delivered through an integrated mentor system, peer-to-peer learning opportunities and regular case reviews, with the programme designed to integrate with, and augment, the PDP requirements, all in a clinically-driven setting free from tie-ins or financial targets."
The Dot programme sees new graduates undertake advanced training and extra practice on surgery, consultations and general practice to accelerate their skills and confidence as well as a digest of bespoke seminars aimed specifically at life in practice and optimising clinical outcomes and confidence.
The programme also includes regular periods of shadowing certificate-holding vets in a diverse range of areas, including ECC, orthopaedics, cardiology and advanced medical work-ups.
Oliver said: "We are proud to develop the programme which we believe will provide a platform for new graduates to apply the skills they’ve learned at university throughout the previous five years, and allow them to excel in their careers.
"This programme will form the first step in an ongoing personal development process and a bright future in our vet practices when they have completed their new graduate training."
Ruby Shorrock is a full-time veterinary surgeon at Pets'n'Vets who is now most of the way through last year’s inaugural Dot programme. She said: "I would heartily recommend the Dot programme to new veterinary graduates.
"The training programme enabled me to become an independent vet with all the support I need and it’s fantastic to be in a locally-owned small veterinary practice where graduates like myself get individual attention in an accredited hospital with the capacity to nurture our skills and personal development and where the gold standard I learned at university is in use every day."
New grads can apply for a place on the Dot programme by logging onto www.new.graduatevet.co.uk and emailing hr@petsnvets.org
Time is running out to nominate your fellow staff members for this year's 'Petplan Pet Insurance Advisor Award'.
The award recognises the hard work and dedication that Pet Insurance Advisors (PIAs) do to highlight the importance of insurance to pet owners so that they are protected financially.
Donna Lewis, President of The British Veterinary Nursing Association said: "The PIA in a practice is an important role for a member of staff to fill and the award is just as relevant as the Vet Nurse of the Year or Receptionist of the Year award. The Petplan PIA Award recognises the individual who fully understands and works to help educate clients and staff about insurance, it is also recognises their passion for their role."
To nominate your dedicated PIA for Petplan's PIA of the Year Awards, please visit www.petplan.co.uk/pia. The PIA of the Year will receive a new laptop and their practice will receive £100 in vouchers!
Nominations close on 3rd September and the nominees will be judged by industry professionals. The winner will be announced at the annual BVNA Congress on 9th October.
Merial has released the results of a survey - carried out in conjunction with VetSurgeon.org - into the use of nutraceuticals for the management of canine joint problems.
The company says the total market for nutraceutical products remains strong, holding a value of £8.9 million* in the UK, and that this indicates that despite increasing economic pressures, nutraceuticals are still valued by veterinary surgeons and owners as an important part of the management approach to canine joint disease.
The survey generated 163 responses. Results showed that whilst 58% of canine patients with joint health problems received only NSAIDs for treatment, 28% of patients received both NSAIDs and a joint health nutraceutical and 14% received a nutraceutical alone, demonstrating the importance that veterinary practitioners place on the use of nutraceuticals. The survey also showed that on average, UK vets stock and recommend at least two nutraceutical products.
Supleneo flex Product Manager Claire Edmunds said: “This eshot survey yielded some interesting results and the email received the second highest recorded opening rate this year, indicating that it is a topic of great interest. The survey confirmed that vets are actively recommending nutraceuticals, alongside NSAIDs, for canine patients with joint health problems. These data also show that the market remains stable as the level of dispensing correlates well with our previous research. To encourage even more growth in this sector and support the launch of Supleneo flex we have produced a range of support materials, including the provision of samples, money off next purchase vouchers and a loyalty programme. In this way we can continue to support vets in their management of canine joint problems.”
For more information call Merial on 0870 6000 123 or contact your Territory Manager.
Veterinary scientist, Dr Alex German and veterinary nurse, Shelley Holden are joining presenter and vet, Mark Evans in a new Channel Four series exploring the secret life of dogs, the first of which airs tonight at 8:00pm.
The three-part series looks at how people's lives and those of their dogs have radically changed in the last 50 years.
Using hidden cameras, episode one investigates how dogs gain weight when their owners are not present or out at work, as well as what research is being done to understand the UK's obesity epidemic in dogs and cats.
Alex, who is head of the University's Weight Management Clinic, said: "Obesity is common in dogs and can lead to a range of illnesses and diseases.
"Although treatment for weight loss has been in existence for some time it has not been without its problems, and owners, with busy lives, can find it difficult to even understand how their dog has gained weight in the first place.
"By showing what dogs get up to out of their owner's sight, this programme explores how understanding our animals' behaviour and habits can help in producing a healthy diet and exercise regime."
Dr German has also contributed to the Channel Four website, which provides information for owners and access to case studies: http://dogs.channel4.com/fat-dogs/
Scrubs Etc Limited has announced the launch of Steribond, a new skin adhesive notable for the fact that it is sterile and can be stored at ambient temperature for up to 18 months.
The product has so far only been launched to a limited number of people at the London Vet Show last November.
According to the company, Steribond is as strong as a 3.0 suture for external sutures and can therefore be used in place of sutures and staples. It has a 10 second setting time, and will stay in place for between 5 to 10 days, depending on the site of injury and other factors.
The product has a precision applicator with a transparent reservoir, allowing the user to see how much adhesive is available and that the applicator is primed. The company says that it allows for a cosmetically neater wound closure, which can be important to customers. In addition, it is a no-sting product which Scrubs Etc says can remove the need to sedate the animal in come circumstances, thereby reducing costs. Steribond is also showerproof.
Steribond is currently on special offer, priced at £83.64 (usual price £102.00 incl. VAT).
For more information, contact Scrubs Etc Ltd on 0870 080 2332 or see: http://www.scrubsuk.com/steribond-veterinary-skin-adhesive-box-of-10-devices.html
Procanicare contains three canine-specific strains of Lactobacillus bacteria, which the company says are proven to improve stool consistency, accelerate recovery following acute episodes of diarrhoea and improve well-being.1
The company also points to a number of studies which it says are evidence of the importance of supporting puppies' intestinal microbiomes.
'New puppy diarrhoea' is, it says, typically due to exposure to factors that are known to risk microbiome disturbance, such as diet change and going to a new home, at a time when the microbial population is at its more sensitive.2
Animalcare says other studies show that microbiome disturbances in early life can have a significant impact on health in adulthood.2,3
James Beaumont, Marketing Manager at Animalcare said: “We often hear from breeders, new puppy owners and vets that puppies which have had Procanicare seem brighter, have firmer stools and less flatulence. With the evidence mounting that the adult intestinal microbiome is shaped in early life and knowing the important and varied role that it has in wider health throughout life, we want to help vets proactively support the GI health of their youngest patients by providing Procanicare for them to trial, with no risk.”
References
Speakers include Dr Ian Stroud, founder and veterinary director of Pet People, an independent small animal practice in Richmond, South West London, Jack Peploe, a veterinary IT expert and Certified Ethical Hacker, and Ciaran Milford, ezyVet’s EMEA sales manager, who has worked with every type of veterinary practice, from aspiring independents right through to established universities and corporate groups.
Lance Rice, creative director at ezyVet, who will moderate the webinar, said: “This webinar is for anyone who feels as though they’ve gone as far as they can in a senior vet or clinic director role, and thinks it might be time to follow their dream of opening their own practice.
“Our speakers are all vastly experienced and ideally positioned to explain what makes a successful launch, as well as the key mistakes and common traps that new owners fall into.
"Ian has a unique understanding of the challenges and opportunities involved with starting a veterinary practice.
"Jack is an expert in helping practices leverage technology to save time, whilst delivering exceptional patient care and bolstering their security posture.
"Ciaran is passionate about helping practices find the right solutions for their needs and business goals."
To register, visit: https://www.ezyvet.com/webinar/starting-a-vet-practice-uk
MSD Animal Health has launched a new Chronogest CR pack for practices starting a dialogue with sheep producer clients about planned breeding for 2013 lamb sales, and is offering a free applicator with every four packs purchased.
The Chronogest CR intra-vaginal sponges, impregnated with 20mg of cronolone (flugestone acetate) synthetic hormone, are now available in foil wrapped packs of 25. The packs protect the sponges from light and moisture.
MSD is reminding practitioners that sponging programmes must be planned at least six weeks in advance of mating, with PMSG-Intervet injections essential at sponge removal.
The new packs of 25 will be available when existing 25, 50 and 100 pack sizes sell out.
Further information on planned breeding - including newsletter copy and sheep producer advisory materials - is available from the MSD Animal Health veterinary support group (VSG) on 01908 685685 or via emailing vet-support.uk@merck.com
Vetoquinol has announced that the vouchers it provides as part of the Epiphen practice support package for monitoring and management of serum levels of phenobarbital will now be provided directly from the veterinary wholesaler and sent with each order.
One or two vouchers are provided with the 30ml and 60ml packs respectively. The vouchers come complete with a pre-paid envelope in which to send samples directly to the laboratory. Each test is valued at £19.80
For further information, contact your local Vetoquinol Territory Manager.
Rabbit Viral Haemorrhagic Disease variant (RVHD2) is a variation of the already recognised Rabbit Viral Haemorrhagic Disease (RVHD1). Vaccines for the original strain of RVHD do not appear to offer long term protection against RVHD2, however vaccines for this new strain are now available in the UK and can be purchased through three UK wholesalers (NVS, Centaur and Henry Schein Animal Health) or direct from the suppliers in Europe. There have been supply issues with this vaccination, however these are hoping to be remedied soon.
RVHD2 is more variable in its rate of disease progression than RVHD1, with presentation ranging from sudden death (with or without bleeding from the orifices), to a longer disease course of three to nine days, increasing the risk of unwell rabbits being brought into practices and in turn increasing the risk of transmission to other pet rabbits. Until vaccination becomes more routine, biosecurity in practices is key to prevent the disease from spreading.
Sean Wensley, BVA President, said: "Although the risk of a rabbit contracting RVHD2 appears highest in situations where rabbits are kept in large groups with regular new additions, such as at breeders or rescue centres, we encourage all owners to speak to their vet about vaccinating their rabbits against RVHD2.
"Veterinary advice from The Rabbit Welfare Association and Fund (RWAF) has stated that the spread of RVHD2 may be facilitated by its apparent slower disease progression compared to RVHD1, and research suggests that we can expect to see RVHD2 starting to predominate in the UK’s wild rabbits over RVHD1 in the next five years or so."
John Chitty, BSAVA Vice President, said: "BSAVA would encourage practices to talk to rabbit owning clients about RVHD2 vaccines, and where there is deemed sufficient risk recommend the vaccine along with the essential vaccination against Myxomatosis – and it should be noted that this must not be done within two weeks of vaccination against RVHD2."
BVZS President and veterinary pathologist Mark Stidworthy said: "It is clear from post mortem examinations and PCR testing over the last 18 months that RVHD2 is now geographically widespread in the UK and all rabbits should be considered at risk from this potentially devastating disease."
Due to recent media coverage of RVHD2, vets may be contacted by concerned owners seeking advice on how to prevent their rabbits contracting this disease - further to vaccinating, vets should recommend rabbits are kept separate from any other rabbits they do not usually interact with; are prevented from having contact with wild rabbits and do not attend any rabbit shows unless already vaccinated.
For a detailed Q&A on RVHD2 from Richard Saunders MRCVS, veterinary advisor to the RWAF, including information on sourcing effective vaccines, visit www.rabbitwelfare.co.uk and click RVHD2 - Filavac Vaccine – FAQs on the home page.
Photo: Larry D. Moore CC BY-SA 3.0.
In the piece, which starts at 1:22:54 here, Gudrun explained that what is seen as “normal” and cute for these dogs, such as snorting and snuffling, is in reality a result of debilitating respiratory problems caused by the squashed faces that have made them so fashionable.
Today also highlighted the fact that flat-faced breeds have experienced a huge boom in popularity recently, driven by celebrity owners, advertising and the media. According to the Kennel Club, the French bulldog is set to knock the labrador off its perch as the UK's most popular breed.
Following the interview Gudrun said: "We shouldn’t be buying and breeding dogs on the way we want them to look - it should always be about prioritising welfare above appearance.
"These are breeds that can suffer just by walking around or eating, which is why we’re calling on the media and advertisers to stop using them in their adverts.
"It is also difficult to turn on the TV, check Instagram or see a celebrity photo without also seeing a brachycephalic breed so it’s not surprising that demand for these dogs is rising."
Gudrun urged anyone thinking about buying a brachycephalic breed to talk to their local vet and think about choosing a healthier breed or crossbreed instead.
The guide, which was first published in 2020, is designed to help veterinary professionals give pet owners sound, independent advice about what to feed their animals.
The guide originally launched with factsheets for both veterinary professionals and pet owners about commercially manufactured, grain-free, raw and home-prepared cooked diets.
The new factsheets cover:
The new factsheets build on considerations for feeding healthy dogs and cats by providing information on the formulation of diet types for pets under veterinary care and those with even more specific nutritional requirements.
The new BSAVA Guide to Nutrition cost £40, reduced to £26 for BSAVA members from: https://www.bsavalibrary.com/
To date most of these imaging procedures have been performed by vets within the group’s small animal first opinion veterinary practices.
The company says its Foundations in Diagnostic Imaging for Nurses training is designed to give its nurses more clinical stature in first opinion practice.
The programme will teach nurses the workings of an x-ray machine, common X-ray positions and contrast material.
It will also cover the principles of CT and MRI, showing how to set up and operate each piece of equipment, and how to support patients through these imaging procedures.
Finally, the course will provide the training nurses need to be able to perform ultrasounds within the current RCVS legal frameworks.
CVS says it believes this is a first in the veterinary profession
Tara Ryan, Chief Veterinary Nursing Officer at CVS said: “Imaging is a brand new area that we are starting to delegate to our nurses.
"Having heavily invested in our small animal first opinion practices over the last decade, we have a wide range of imaging equipment at many of our sites.
“Excitingly, this programme will open up the ability for nurses to start to contribute more information - to help vets identify and diagnose conditions and diseases in patients.
"It is another big step that we are taking to empower our brilliant nurses and to enable them to make a great clinical contribution towards the care of our patients – and to be the nurses they want to be.”
CVS is prioritising the consulting room and Schedule 3 delegated tasks as important areas for improving what it calls 'nurse optimisation'.
The company recognises that 'buy in' from veterinary surgeons is vital to the success of its efforts to optimise the role of its nurses, and the group has also published guidelines to provide clarity around effective delegation under Schedule 3.
Intervet/Schering-Plough Animal Health has announced that it has received approval for the intramuscular (IM) route of administration of Nuflor Minidose 450 mg/ml, a florfenicol-containing broad-spectrum antibiotic for the management of bovine respiratory disease (BRD).
Nuflor Minidose was approved initially in 2008 for subcutaneous (SC) use only and the now approved IM administration route is a line extension. According to Intervet/Schering Plough, IM administration (20 mg/kg administered twice, 48h apart) offers additional flexibility for the veterinary surgeon when treating cattle for BRD.
The company adds that Nuflor Minidose is the florfenicol injectable formulation which offers the lowest injection volume, which in particular is practical when treating heavier animals (thereby avoiding large injection volumes). The withdrawal period after IM administration of NUFLOR Minidose is only 37 days and is considerably shorter as compared to 64 days after SC use (40 mg/kg body weight injected once).
Francis Adriaens, Global Marketing Director, Global Ruminants Business Unit at Intervet/Schering-Plough Animal Health said: "Our customers requested the IM claim when Nuflor Minidose was first introduced and we are delighted to be able to recommend this route of administration hence forth."
Nuflor Minidose is indicated for preventive and therapeutic treatment of BRD in cattle caused by Mannheimia haemolytica, Pasteurella multicoda and Histophilus somni susceptible to florfenicol. The presence of the disease in the herd should be confirmed before administering preventive treatment.
Ceva Animal Health has produced a new advisory leaflet about enzootic abortion control and vaccination strategy in sheep to help vets explain the best prevention protocols to clients.
According to the company, it is estimated that around half of the 400,000 infectious abortions in UK sheep each year are from enzootic abortion caused by Chlamydophila abortus, but timely vaccination programmes can prevent such dramatic losses.
The eight-page leaflet explains how enzootic abortion can spread, why prevention is better than cure, the importance of timely vaccination of ewe lambs and replacement stock, how vaccination programmes make good economic sense and the benefits of using Cevac Chlamydia, Ceva Animal Health's live enzootic abortion vaccine as part of the control programme.
Carol Atkinson, reprodAction's product manager said: "Cevac Chlamydia receives consistently good feedback from vets, many of whom have enthusiastically volunteered their praise for the product to our territory managers. We thought a leaflet would be a constructive way to share views, giving vets the chance to hear about the advantages of vaccination and to provide them with the tools to explain to their clients why vaccinating against enzootic abortion is cost worthy."
For further information contact Ceva Animal Health Ltd, Unit 3, Anglo Office Park, White Lion Road, Amersham, Bucks, HP7 9FB, Telephone +44 (0) 1494 781510.
During a welcome reception, leaders and representatives of the veterinary profession were given tours of the facility and shown the advanced surgical training and ultrasound equipment available.
The wet-lab is equipped with 13 electrically-adjustable surgical tables, each with their own operating light and an audio-visual (a/v) system connecting them to the lecturer. The a/v system enables the lecturer to carry out demonstrations of procedures and to provide individual or group guidance to delegates practising surgical and other practical techniques.
Delegates are able to use the latest surgical and diagnostic equipment, including IM3 dental equipment, Logic E ultrasound machines and new surgical instrumentation for a range of orthopaedic and soft tissue procedures.
Improve's Managing Director, David Babington MRCVS, said: "Newly qualified vets have a huge need for additional training in practical skills and this demand extends into their ongoing professional life as new techniques are developed and existing ones refined.
"We already offer practical training facilities to delegates attending our training programmes at our HQ in Swindon but wanted to make it easier for vets and nurses in the north of the UK to access these facilities. This new 'wet-lab' offers an ideal training environment for our delegates to accelerate their learning and take new skills back to their practice."
He added: "Learning new techniques, whether surgical or diagnostic, is a proven way to boost practice profitability because it reduces the need to refer more complex cases. We hear from many of those who have trained with us that their increased skillset has enhanced their job satisfaction and increased the volume of cases they treat. In many cases, the training has paid for itself many times over. We are excited at the prospect of helping even more veterinary professionals to advance their skills."
The impact of the College's research on society was similarly highly-ranked, with 83% being scored 4*, and 7.5 of the 9 impact case studies submitted found to have “outstanding reach and significance”.
Additionally, there has been a 54% increase in the number of full time equivalent academic staff submitted since the last assessment – establishing the RVC as the largest veterinary research institution in the country.
The impact case studies submitted by the RVC covered a range of research areas, including those which advance clinical practice; protect public health by enhancing food safety; inform World Health Organisation and the Food and Agriculture Organisation policy on the control of disease afflicting some of poorest people in the world; and tackle antimicrobial resistance through innovations in drug delivery.
The College says the results also highlight its holistic and transdisciplinary approach to research, with researchers, teachers, clinicians and pathologists working collaboratively to ensure ‘real world’ impact and advances in clinical practice.
Professor Jonathan Elliott, Professor of Veterinary Clinical Pharmacology at the RVC, said: “REF 2021 has recognised the outstanding reach and significance of the impact of our research which is so pleasing to see.
"I know all my academic colleagues are motivated to innovate in order to make a difference to lives of people and those of the animals they keep.
"Our submission truly reflects the breadth of scholarship at the RVC which generates the new knowledge we teach our students, the high quality of which has been endorsed by this external review.”
VetIT is launching a new suite of practice management software this month, which it claims will wipe out IT support worries while also giving vets secure access to their records wherever there's an internet connection.
Designed for practice-based and mobile vets, its developer says the near-universal access of the system will make VetIT ideal for the progressive and forward-thinking veterinary practice, particularly those with multiple locations. Early clients are already seeing the benefits of the system, which has been four years in development.
VetIT's Tony Houghton said: "The software offers practices a host of new features, all of them designed to increase usability, enhance revenue, reduce running costs and eliminate IT concerns. And because the new system has been developed in partnership with a well-established veterinary practice, VetIT sees and does things from a vet's perspective.
"During the development phase, our practice partner told us that existing packages were unwieldy - whether in their day-to-day operation, the ability to see and share data, or the 'back office' administration required. So we designed VetIT from scratch, to work in the most user-friendly manner."
According to Mr Houghton, the most significant difference is in how the software works - and in recognising that most practices expect IT systems to 'happen' in the background, rather than devouring precious time. "Existing packages are physically located in your practice - usually on a dedicated server, requiring daily back-ups and maintenance.
"VetIT, conversely, is a 'web-hosted solution' - like Sage Online or for that matter, Facebook - which means it's accessible to users wherever there's a browser and an internet connection: main or branch practice, home or out in the field. Log in from anywhere and you'll always see the same data.
"Practice data is held securely at a remote location and, with automatic back-up systems, some of the biggest worries about onsite IT systems - theft, fire, flooding and protection from computer viruses - are removed immediately.
"In the event of system maintenance or issues, customers talk to a friendly, UK-based support and development team, who can access and modify the system in real time; practices won't have to wait for an engineer to attend. In fact, we have a very content practice in Oman now running the system; the installation and set-up has all been carried out from a distance."
By removing the 'IT headache', Mr Houghton says practices choosing VetIT will be able to run their businesses more effectively, while developing closer, more valuable relationships with customers.
He said: "The web-based system allows vets' customers to log-in to 'their' VetIT, where they can check records, pay bills, or place orders. Practices can also maintain and build a relationship with customers via e-mail and SMS reminders of appointments, check-ups, treatments due and so on."
As for running costs and pricing, Mr Houghton cites pre-launch studies showing the potential for productivity gains in practices deploying VetIT, while the system's clear pricing - from low-cost start-up practices to corporate licensing for multi-site operations - gives peace of mind with smooth, predictable costs through the system's life. "You don't have to buy expensive computer hardware like servers and back-up systems, and pay-as-you-go pricing eliminates up-front software licensing costs."
Mr Houghton says users in so-called 'notspots' - areas of the country where broadband connections run at less than 2Mbps or are non-existent - need not feel left out, either. "We've designed the system to be as fast as possible, with no heavy data-transfer requirements. In fact, data transfer within the system is so well optimised that it will even work with a dial-up connection or mobile broadband."
More information about VetIT is at http://www.vetit.co.uk/, or contact Nick Cole.
The partnership happened after Lumbry Park’s Clinical Director, veterinary cardiologist, Dr Luca Ferasin and his wife Heidi had a son, Mattia, with multiple and life-threatening congenital heart defects. During their son's subsequent treatment, which involved seven hours of successful open heart surgery, Dr Ferasin and his wife got to know Dr Caner Salih, a consultant paediatric cardiac surgeon and member of the team caring for Mattia. So when Dr Salih acquired French Bulldog puppy called Büdu a few weeks later, and a heart murmur was detected during his first visit to the vet, he turned to Dr Ferasin for advice.
Dr Ferasin diagnosed Büdu with the congenital heart condition Perimembranous Ventricular Septal Defect (VSD). A VSD is characterised by a hole between the left and right ventricles of the heart which causes an abnormal blood flow between the two chambers. Ironically, a large VSD was one of the multiple heart defects successfully corrected during Mattia’s life-saving cardiac surgery.
Dr Salih said: "I first met Dr Ferasin and Heidi under one of the most stressful circumstances a parent can experience, that of waiting for a child to undergo life-saving cardiac surgery. Sometime later I had first-hand experience of something not comparable but nonetheless very stressful of having to wait for the results of a diagnostic test which Dr Ferasin was able to provide for our newly acquired puppy. I appreciated more than ever the importance of knowing that our newest family member was in the most capable of hands."
Dr Ferasin said: "The related stories of Mattia and Büdu highlight the remarkable similarities between paediatric and small animal medicine, not only in terms of medical conditions, diagnostic techniques and therapeutic procedures, but also in terms of the psychological, emotional and social importance of the human-animal bond – in both directions. After all, just like babies and young children, veterinary patients cannot communicate with us - while their ‘parents’ have the same need for reassurance that their beloved ‘baby’ will recover.
"Our partnership with the Evelina London Children’s Hospital will celebrate these similarities and promote the concept of ‘One Health’ in a bid to advance both human and veterinary medicine. By working closely with the Evelina London, we aim to contribute positively to the development of novel techniques, research and therapies in both our children and in companion animals. We’re planning a range of initiatives, including fundraising and collaborations with the clinical staff at Lumbry Park and the Evelina London, in particular with those in the cardiology and cardiac surgery departments. We’re also planning social events, such as advanced pet-therapy sessions for children undergoing treatment at the Evelina and their families, including direct interaction with our veterinary patients with similar conditions."
He added: "Thanks to the dedicated team at the Evelina London Children’s Hospital, Mattia is thriving and is a happy, healthy and fun-loving little boy. He will continue to visit the hospital for reassessments as he grows. Büdu visited us again at Lumbry Park during 2016 for a reassessment and an ultrasound of his heart showed the spontaneous closure of his VSD, resulting in the resolution of his condition. This is a rare but fantastic outcome which, to the best of our knowledge, has only been reported in a couple of canine cases in the veterinary literature. What better reason to cement the bond between human and veterinary medicine!"
Dr Salih added: "Many people do not appreciate the amount of shared learning that has, for decades, occurred between the study of animals and medicine. Many of the advances in areas of human healthcare we embrace today simply could not exist without this relationship – and open heart surgery is one. The Evelina is delighted to be collaborating with Lumbry Park on this exciting venture."